Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: arnold silver who wrote (133)	3/12/2003 1:27:56 PM
From: Sergio H	Read Replies (1) \| Respond to of 174

Arnie, DFIB is the only pure play in the growing defibrillator niche. The catalysts that should continue to propel this stock include: The Survivalink overhang is now history. This company has established its niche and is increasing market share. There is pending legislation accross every state in the U.S. as well as internationally that will increase demand for DFIB's products. There's a good possibility that this company will be a buyout target for any of the larger med device companies that are looking to enter the defib market. *The Zoll law suit set up Medtronic and Phillips for similar fates. Since we share common interest in at least two stocks have a look at ALU. Yesterday's sell off was without merit. The co. should soon settle with their insurance carrier or file a law suit.